Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ahmet Aydin

Concepts (145)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
7
2022
158
3.060
 Why?
Penile Neoplasms
6
2021
44
3.000
 Why?
Carcinoma, Squamous Cell
5
2021
326
1.930
 Why?
Carcinoma, Transitional Cell
3
2022
51
1.540
 Why?
Kidney Neoplasms
5
2021
174
1.510
 Why?
Prostatic Neoplasms
3
2020
384
1.510
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
76
1.430
 Why?
Carcinoma, Renal Cell
4
2021
101
1.000
 Why?
Immunotherapy
6
2021
235
0.870
 Why?
Pheochromocytoma
1
2023
36
0.860
 Why?
Adrenal Gland Neoplasms
1
2023
51
0.850
 Why?
Urothelium
1
2021
17
0.730
 Why?
BCG Vaccine
2
2020
16
0.710
 Why?
Diskectomy
1
2020
12
0.700
 Why?
Intervertebral Disc Displacement
1
2020
12
0.700
 Why?
Neoadjuvant Therapy
5
2022
120
0.700
 Why?
Indocyanine Green
1
2020
34
0.700
 Why?
Cancer Vaccines
1
2021
80
0.690
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.680
 Why?
CD8-Positive T-Lymphocytes
1
2021
125
0.680
 Why?
Adjuvants, Immunologic
1
2020
51
0.660
 Why?
Endoscopy
1
2020
119
0.660
 Why?
Patient Readmission
1
2021
227
0.650
 Why?
Anesthesia, Local
1
2019
16
0.650
 Why?
Male
25
2021
25910
0.640
 Why?
Edetic Acid
1
2019
14
0.640
 Why?
Tumor Suppressor Proteins
2
2021
128
0.640
 Why?
Immunotherapy, Adoptive
1
2021
163
0.640
 Why?
Testicular Neoplasms
4
2021
45
0.630
 Why?
Ureteral Neoplasms
1
2019
11
0.630
 Why?
Prostate-Specific Antigen
1
2019
44
0.630
 Why?
Papillomavirus Infections
1
2021
168
0.620
 Why?
Oligopeptides
1
2019
95
0.600
 Why?
Neoplasm Recurrence, Local
4
2021
629
0.560
 Why?
Humans
31
2023
50509
0.550
 Why?
Cystectomy
3
2022
49
0.550
 Why?
Retrospective Studies
11
2022
6263
0.530
 Why?
Arteriovenous Fistula
1
2016
30
0.520
 Why?
Middle Aged
13
2021
12614
0.500
 Why?
Aged
12
2021
9743
0.490
 Why?
Neoplasms, Germ Cell and Embryonal
3
2021
23
0.470
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1000
0.450
 Why?
Lymphatic Metastasis
4
2021
222
0.420
 Why?
Neoplasm Grading
4
2020
122
0.400
 Why?
Female
15
2023
27086
0.380
 Why?
Neoplasm Invasiveness
3
2022
269
0.380
 Why?
Treatment Outcome
8
2022
5285
0.360
 Why?
Tumor Microenvironment
3
2021
222
0.350
 Why?
Lymph Nodes
2
2021
257
0.310
 Why?
Adult
9
2023
13583
0.270
 Why?
Prognosis
3
2020
1978
0.250
 Why?
Neoplasm Metastasis
3
2021
232
0.230
 Why?
Postoperative Complications
3
2021
1033
0.230
 Why?
Quality of Life
2
2020
852
0.220
 Why?
Adrenalectomy
1
2023
35
0.220
 Why?
Adrenal Glands
1
2023
40
0.220
 Why?
Neoplasm Staging
3
2021
746
0.200
 Why?
Aged, 80 and over
2
2021
3228
0.200
 Why?
Deoxycytidine
1
2022
30
0.200
 Why?
Retroperitoneal Space
2
2021
27
0.200
 Why?
Cohort Studies
3
2021
1452
0.190
 Why?
Muscles
1
2022
104
0.190
 Why?
Mycobacterium bovis
1
2021
11
0.180
 Why?
Antigens, Differentiation, Myelomonocytic
1
2021
39
0.180
 Why?
Lymph Node Excision
2
2021
131
0.180
 Why?
Aftercare
1
2021
72
0.180
 Why?
T-Lymphocytes
2
2020
325
0.180
 Why?
Teratoma
1
2021
22
0.180
 Why?
Interleukin-2
1
2021
71
0.180
 Why?
Diskectomy, Percutaneous
1
2020
1
0.180
 Why?
Reference Standards
1
2020
52
0.180
 Why?
Tomography, Emission-Computed
1
2020
53
0.180
 Why?
Fluorouracil
1
2020
58
0.180
 Why?
Lymphocyte Activation
1
2021
164
0.170
 Why?
Cisplatin
1
2022
286
0.170
 Why?
Microscopy
1
2020
59
0.170
 Why?
Recurrence
2
2019
659
0.170
 Why?
Carcinoma in Situ
1
2020
73
0.170
 Why?
Antigens, CD
1
2021
222
0.170
 Why?
Hemostasis, Endoscopic
1
2019
5
0.170
 Why?
Sentinel Lymph Node Biopsy
1
2020
118
0.170
 Why?
Lumbar Vertebrae
1
2020
102
0.160
 Why?
Survival Rate
2
2019
909
0.160
 Why?
Gallium Isotopes
1
2019
2
0.160
 Why?
Gallium Radioisotopes
1
2019
10
0.160
 Why?
Kidney Pelvis
1
2019
17
0.160
 Why?
Patient Discharge
1
2021
321
0.160
 Why?
Gastrointestinal Hemorrhage
1
2019
80
0.160
 Why?
Disease-Free Survival
1
2020
444
0.160
 Why?
Feasibility Studies
1
2020
391
0.150
 Why?
Genomics
1
2020
279
0.150
 Why?
Papillomavirus Vaccines
1
2019
67
0.150
 Why?
Urologic Neoplasms
1
2018
12
0.150
 Why?
Ureteral Obstruction
1
2019
61
0.150
 Why?
Carcinoma, Papillary
1
2018
47
0.150
 Why?
Antineoplastic Agents
3
2020
1172
0.140
 Why?
Genetic Predisposition to Disease
1
2020
511
0.140
 Why?
Cells, Cultured
1
2021
1571
0.140
 Why?
Biopsy
1
2019
588
0.140
 Why?
Cell Proliferation
1
2021
985
0.140
 Why?
Anticoagulants
1
2019
256
0.130
 Why?
Renal Artery
1
2016
33
0.130
 Why?
Gene Expression Regulation, Neoplastic
1
2020
833
0.130
 Why?
Nephrectomy
1
2016
81
0.130
 Why?
Time Factors
2
2020
2934
0.130
 Why?
Hospitalization
1
2019
675
0.120
 Why?
Urinary Tract Infections
1
2015
51
0.120
 Why?
Laparoscopy
1
2016
173
0.110
 Why?
Prospective Studies
1
2020
2378
0.110
 Why?
Risk Factors
2
2019
3724
0.110
 Why?
Kidney Failure, Chronic
1
2015
201
0.100
 Why?
Kidney Transplantation
1
2015
189
0.100
 Why?
Chemotherapy, Adjuvant
2
2020
121
0.080
 Why?
Kaplan-Meier Estimate
2
2021
464
0.080
 Why?
Follow-Up Studies
3
2020
2241
0.080
 Why?
Survival Analysis
2
2021
661
0.070
 Why?
Turkey
2
2019
17
0.070
 Why?
T-Lymphocyte Subsets
1
2021
39
0.040
 Why?
Immune System
1
2021
43
0.040
 Why?
Administration, Topical
1
2020
57
0.040
 Why?
Forkhead Transcription Factors
1
2021
110
0.040
 Why?
Urinary Bladder
1
2020
93
0.040
 Why?
Peptic Ulcer Hemorrhage
1
2019
5
0.040
 Why?
Duodenal Ulcer
1
2019
13
0.040
 Why?
Stomach Ulcer
1
2019
8
0.040
 Why?
Patient Selection
1
2020
259
0.040
 Why?
Treatment Failure
1
2019
118
0.040
 Why?
Macrophages
1
2021
364
0.040
 Why?
Socioeconomic Factors
1
2020
591
0.040
 Why?
Health Facilities
1
2017
40
0.040
 Why?
Oncolytic Virotherapy
1
2017
18
0.040
 Why?
Combined Modality Therapy
1
2018
641
0.030
 Why?
Adolescent
2
2019
6447
0.030
 Why?
Mutation
1
2021
1281
0.030
 Why?
Clinical Trials as Topic
1
2017
486
0.030
 Why?
Child
2
2019
6910
0.030
 Why?
Registries
1
2017
563
0.030
 Why?
Graft Survival
1
2015
159
0.030
 Why?
Cytokines
1
2017
606
0.030
 Why?
Antibodies, Monoclonal
1
2017
462
0.030
 Why?
Mice
1
2020
5687
0.020
 Why?
Child, Preschool
1
2019
3944
0.020
 Why?
Young Adult
1
2018
4106
0.020
 Why?
United States
1
2017
4958
0.020
 Why?
Animals
1
2020
13124
0.020
 Why?
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (145) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department